Logo image of LASR

NLIGHT INC (LASR) Stock Fundamental Analysis

USA - NASDAQ:LASR - US65487K1007 - Common Stock

32.56 USD
+0.02 (+0.06%)
Last: 10/16/2025, 1:37:49 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LASR. LASR was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. LASR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LASR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LASR had negative earnings in the past year.
In the past year LASR has reported a negative cash flow from operations.
In the past 5 years LASR always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: LASR reported negative operating cash flow in multiple years.
LASR Yearly Net Income VS EBIT VS OCF VS FCFLASR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

LASR's Return On Assets of -15.91% is on the low side compared to the rest of the industry. LASR is outperformed by 69.35% of its industry peers.
LASR has a worse Return On Equity (-21.75%) than 68.55% of its industry peers.
Industry RankSector Rank
ROA -15.91%
ROE -21.75%
ROIC N/A
ROA(3y)-17.55%
ROA(5y)-13.6%
ROE(3y)-21.54%
ROE(5y)-16.79%
ROIC(3y)N/A
ROIC(5y)N/A
LASR Yearly ROA, ROE, ROICLASR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

Looking at the Gross Margin, with a value of 21.18%, LASR is doing worse than 65.32% of the companies in the same industry.
LASR's Gross Margin has declined in the last couple of years.
LASR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.55%
GM growth 5Y-10.9%
LASR Yearly Profit, Operating, Gross MarginsLASR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

6

2. Health

2.1 Basic Checks

LASR does not have a ROIC to compare to the WACC, probably because it is not profitable.
LASR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LASR has been increased compared to 5 years ago.
LASR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LASR Yearly Shares OutstandingLASR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LASR Yearly Total Debt VS Total AssetsLASR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

LASR has an Altman-Z score of 11.64. This indicates that LASR is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 11.64, LASR belongs to the best of the industry, outperforming 89.52% of the companies in the same industry.
LASR has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of LASR (0.09) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 11.64
ROIC/WACCN/A
WACC9.1%
LASR Yearly LT Debt VS Equity VS FCFLASR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

LASR has a Current Ratio of 5.63. This indicates that LASR is financially healthy and has no problem in meeting its short term obligations.
LASR's Current ratio of 5.63 is amongst the best of the industry. LASR outperforms 84.68% of its industry peers.
A Quick Ratio of 4.41 indicates that LASR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.41, LASR belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.63
Quick Ratio 4.41
LASR Yearly Current Assets VS Current LiabilitesLASR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.00% over the past year.
Looking at the last year, LASR shows a quite strong growth in Revenue. The Revenue has grown by 9.80% in the last year.
Measured over the past years, LASR shows a small growth in Revenue. The Revenue has been growing by 2.37% on average per year.
EPS 1Y (TTM)28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y-9.75%
Revenue growth 5Y2.37%
Sales Q2Q%22.22%

3.2 Future

Based on estimates for the next years, LASR will show a very strong growth in Earnings Per Share. The EPS will grow by 43.87% on average per year.
Based on estimates for the next years, LASR will show a quite strong growth in Revenue. The Revenue will grow by 14.93% on average per year.
EPS Next Y106.9%
EPS Next 2Y43.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.48%
Revenue Next 2Y14.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LASR Yearly Revenue VS EstimatesLASR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
LASR Yearly EPS VS EstimatesLASR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LASR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 718.47, LASR can be considered very expensive at the moment.
LASR's Price/Forward Earnings is on the same level as the industry average.
LASR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.04.
Industry RankSector Rank
PE N/A
Fwd PE 718.47
LASR Price Earnings VS Forward Price EarningsLASR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LASR Per share dataLASR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as LASR's earnings are expected to grow with 43.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.87%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LASR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NLIGHT INC

NASDAQ:LASR (10/16/2025, 1:37:49 PM)

32.56

+0.02 (+0.06%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)10-30 2025-10-30/amc
Inst Owners85.58%
Inst Owner Change-0.07%
Ins Owners6%
Ins Owner Change4.4%
Market Cap1.62B
Analysts83.08
Price Target28.65 (-12.01%)
Short Float %4.55%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.18%
Min EPS beat(2)79%
Max EPS beat(2)165.36%
EPS beat(4)3
Avg EPS beat(4)50.09%
Min EPS beat(4)-48.92%
Max EPS beat(4)165.36%
EPS beat(8)6
Avg EPS beat(8)27.29%
EPS beat(12)8
Avg EPS beat(12)20.48%
EPS beat(16)11
Avg EPS beat(16)13.02%
Revenue beat(2)2
Avg Revenue beat(2)8.03%
Min Revenue beat(2)6.5%
Max Revenue beat(2)9.56%
Revenue beat(4)2
Avg Revenue beat(4)3.82%
Min Revenue beat(4)-0.43%
Max Revenue beat(4)9.56%
Revenue beat(8)5
Avg Revenue beat(8)2.67%
Revenue beat(12)5
Avg Revenue beat(12)0.91%
Revenue beat(16)5
Avg Revenue beat(16)-0.07%
PT rev (1m)0%
PT rev (3m)81.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)117.94%
EPS NY rev (1m)157.9%
EPS NY rev (3m)116.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.14%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)9.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 718.47
P/S 7.49
P/FCF N/A
P/OCF N/A
P/B 7.52
P/tB 8
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)0.05
Fwd EY0.14%
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS4.35
BVpS4.33
TBVpS4.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.91%
ROE -21.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.18%
FCFM N/A
ROA(3y)-17.55%
ROA(5y)-13.6%
ROE(3y)-21.54%
ROE(5y)-16.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.55%
GM growth 5Y-10.9%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.96%
Cap/Sales 4.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.63
Quick Ratio 4.41
Altman-Z 11.64
F-Score4
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)72.24%
Cap/Depr(5y)107.55%
Cap/Sales(3y)5.17%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
EPS Next Y106.9%
EPS Next 2Y43.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.8%
Revenue growth 3Y-9.75%
Revenue growth 5Y2.37%
Sales Q2Q%22.22%
Revenue Next Year21.48%
Revenue Next 2Y14.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-75.1%
OCF growth 3YN/A
OCF growth 5YN/A